Given that KLF1 levels may be playing a directive role in erythroid/megakaryocyte bipotential decisions, we focused on myeloproliferative neoplasms (MPNs) as cells whose aberrant properties might result from expression of mutated KLF1. The gene discussed is KLF1; the disease is myeloproliferative disorder.